Our data demonstrate that PD-L1 might be useful to stratify COVID-19 patient prognosis as high levels of sPD-L1 correlated with validated prognostic biomarkers especially lymphopenia and high levels of CRP as well as with an increase of LOS and mortality rate. Here, CRP is linked to COVID-19.